- Home
- NMRA vs JMSB Comparison
NMRA vs JMSB Comparison
Compare NMRA & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NMRA | JMSB |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.4M | 270.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | NMRA | JMSB |
|---|---|---|
| Price | $1.74 | $21.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $8.00 | ★ $22.50 |
| AVG Volume (30 Days) | ★ 986.1K | 22.4K |
| Earning Date | 11-06-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.40% |
| EPS Growth | N/A | ★ 18.50 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $59,274,000.00 |
| Revenue This Year | N/A | $19.50 |
| Revenue Next Year | N/A | $12.72 |
| P/E Ratio | ★ N/A | $15.27 |
| Revenue Growth | N/A | ★ 11.69 |
| 52 Week Low | $0.61 | $13.81 |
| 52 Week High | $11.57 | $21.60 |
Technical Indicators
Market Signals| Indicator | NMRA | JMSB |
|---|---|---|
| Relative Strength Index (RSI) | 30.06 | 60.98 |
| Support Level | $1.68 | $19.45 |
| Resistance Level | $2.36 | $21.50 |
| Average True Range (ATR) | 0.13 | 0.49 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 6.53 | 81.45 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.